Recent progress of palmitoyl transferase DHHC3 as a novel antitumor target

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• DHHC3 is a palmitoyl acyltransferase crucial for mammalian palmitoylation.
• DHHC3 exhibits a significant protumorigenic effect across various cancer types by modifying substrate proteins.
• Dysregulation of DHHC3 contributes to cancer progression.

Purpose of the Study:

• To review the research progress on DHHC3 as a potential antitumor target.
• To explore the expression patterns of DHHC3 in tumors, its substrate proteins, and underlying mechanisms.
• To discuss recent advancements in identifying DHHC3 protein structures and inhibitors for drug design.

Main Methods:

• Literature review of studies on DHHC3 expression, substrates, and mechanisms in cancer.
• Analysis of recent findings on DHHC3 protein structure determination.
• Review of current inhibitor development strategies for DHHC3.

Main Results:

• DHHC3 expression is elevated in tumors, correlating with its protumorigenic activity.
• Specific substrate proteins and their modification by DHHC3 are identified, elucidating its oncogenic pathways.
• Advances in structural biology have provided insights for rational drug design targeting DHHC3.

Conclusions:

• DHHC3 represents a viable and novel target for anticancer drug development.
• Understanding DHHC3's role in posttranslational modification is key to exploiting it as an antitumor strategy.
• Further research into DHHC3 inhibitors and structural biology will accelerate the development of targeted cancer therapies.